An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The primary objective of the trial is to describe the long-term safety and tolerability of TEV-56286 administered orally for the treatment of adult participants with Multiple System Atrophy (MSA). A secondary objective of the trial is to further describe the safety and tolerability of TEV-56286. The planned total duration of the trial is approximately 100 weeks.
Epistemonikos ID: 36852b2e0298c3dc7e52c9fb917a5022e290be55
First added on: Sep 30, 2025